Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33.
Saved in:
| Title: | Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. |
|---|---|
| Authors: | Webster LR; Sydney Medical School - Westmead, University of Sydney, Westmead †Westmead Institute for Cancer Research, Westmead ‡Westmead Millennium Institute, Westmead §Tissue Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead ||Translational Oncology, Sydney West Cancer Network, Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead ¶Anatomical Pathology, St Vincent's Hospital, Darlinghurst **Prince of Wales Clinical School, University of New South Wales, Randwick ††School of Medical Sciences University of New South Wales, Randwick ‡‡School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia §§Genetics Branch, National Cancer Institute, Bethesda MD USA ||||these authors contributed equally to this work., Provan PJ, Graham DJ, Byth K, Walker RL, Davis S, Salisbury EL, Morey AL, Ward RL, Hawkins NJ, Clarke CL, Meltzer PS, Balleine RL |
| Source: | Pathology [Pathology] 2013 Dec; Vol. 45 (7), pp. 629-36. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 24247619 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Webster+LR%22">Webster LR</searchLink>; Sydney Medical School - Westmead, University of Sydney, Westmead †Westmead Institute for Cancer Research, Westmead ‡Westmead Millennium Institute, Westmead §Tissue Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead ||Translational Oncology, Sydney West Cancer Network, Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead ¶Anatomical Pathology, St Vincent's Hospital, Darlinghurst **Prince of Wales Clinical School, University of New South Wales, Randwick ††School of Medical Sciences University of New South Wales, Randwick ‡‡School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia §§Genetics Branch, National Cancer Institute, Bethesda MD USA ||||these authors contributed equally to this work.<br /><searchLink fieldCode="AU" term="%22Provan+PJ%22">Provan PJ</searchLink><br /><searchLink fieldCode="AU" term="%22Graham+DJ%22">Graham DJ</searchLink><br /><searchLink fieldCode="AU" term="%22Byth+K%22">Byth K</searchLink><br /><searchLink fieldCode="AU" term="%22Walker+RL%22">Walker RL</searchLink><br /><searchLink fieldCode="AU" term="%22Davis+S%22">Davis S</searchLink><br /><searchLink fieldCode="AU" term="%22Salisbury+EL%22">Salisbury EL</searchLink><br /><searchLink fieldCode="AU" term="%22Morey+AL%22">Morey AL</searchLink><br /><searchLink fieldCode="AU" term="%22Ward+RL%22">Ward RL</searchLink><br /><searchLink fieldCode="AU" term="%22Hawkins+NJ%22">Hawkins NJ</searchLink><br /><searchLink fieldCode="AU" term="%22Clarke+CL%22">Clarke CL</searchLink><br /><searchLink fieldCode="AU" term="%22Meltzer+PS%22">Meltzer PS</searchLink><br /><searchLink fieldCode="AU" term="%22Balleine+RL%22">Balleine RL</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220175411%22">Pathology</searchLink> [Pathology] 2013 Dec; Vol. 45 (7), pp. 629-36. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0175411 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-3931 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200313025%22">00313025 </searchLink><i>NLM ISO Abbreviation: </i>Pathology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24247619 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/PAT.0000000000000004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 629 Titles: – TitleFull: Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Webster LR – PersonEntity: Name: NameFull: Provan PJ – PersonEntity: Name: NameFull: Graham DJ – PersonEntity: Name: NameFull: Byth K – PersonEntity: Name: NameFull: Walker RL – PersonEntity: Name: NameFull: Davis S – PersonEntity: Name: NameFull: Salisbury EL – PersonEntity: Name: NameFull: Morey AL – PersonEntity: Name: NameFull: Ward RL – PersonEntity: Name: NameFull: Hawkins NJ – PersonEntity: Name: NameFull: Clarke CL – PersonEntity: Name: NameFull: Meltzer PS – PersonEntity: Name: NameFull: Balleine RL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2013 Dec Type: published Y: 2013 Identifiers: – Type: issn-electronic Value: 1465-3931 Numbering: – Type: volume Value: 45 – Type: issue Value: 7 Titles: – TitleFull: Pathology Type: main |
| ResultId | 1 |